Radar Therapeutics
PrivateLast Round
Seed
May 23, 2024
Total Funding Raised
$13.4M
Company Overview
Radar Therapeutics operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Seed round in May 2024.
Radar Therapeutics is a biotechnology company developing programmable precision mRNA-based therapeutics that use RNA sensors to target pathogenic cells based on their transcriptional signatures.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radar Therapeutics Comparables
Compare Radar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strand Therapeutics | 82% | |
| Therna Biosciences | 75% | |
| Senti Biosciences | 73% |
For institutional investors. Book with your work email.
Radar Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Radar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Seed |
| NFX | Seed |
| Pear VC | Seed |
| Biovision Ventures | Seed |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2024
$13.4M round led by NFX
For institutional investors. Book with your work email.
Radar Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Radar Therapeutics's valuation, stock price, and market status.
Is Radar Therapeutics a public or private company?
Radar Therapeutics is a private company.
What is the current stock price of Radar Therapeutics?
Radar Therapeutics is a private company, so its shares have no public market price. Caplight tracks Radar Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Radar Therapeutics worth (valuation)?
Valuation information for Radar Therapeutics is not publicly available.
Can I buy Radar Therapeutics stock?
Radar Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Radar Therapeutics's last funding round?
Radar Therapeutics's most recent funding round was Seed on May 23, 2024.
Who are the main investors in Radar Therapeutics?
Key investors in Radar Therapeutics include NFX.
Will Radar Therapeutics IPO soon?
No public IPO plans have been announced for Radar Therapeutics.
How can I track Radar Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Radar Therapeutics's shares on secondary markets.